The Hidden Cost of Tail Spend in Manufacturing
Manufacturers lose 5-20% through tail spend—low-value purchases creating hidden costs. Learn how AI and automation recover millions in fragmented procurement.
Read post 
Innovative Hydrogel Injection Offers Hope for Osteoporosis Treatment
Researchers at the Ecole Polytechnique Fédérale de Lausanne (EPFL) have developed an injectable hydrogel that significantly boosts bone density, potentially revolutionizing osteoporosis treatment. Conducted with rats, this study demonstrated rapid improvements in bone strength when combined with traditional osteoporosis medications,…
Read post
Innovative Nano-Architected Materials Developed with Machine Learning and 3D Printing
Researchers at the University of Toronto, in collaboration with the Korea Advanced Institute of Science & Technology, have utilized machine learning and 3D printing to create advanced nano-architected materials. These materials combine the strength of carbon steel with the lightness…
Read post
Sierra Space’s Dream Chaser Achieves Major NASA Testing Milestone
Sierra Space has successfully completed a critical testing milestone for its Dream Chaser spaceplane in collaboration with NASA. The test, conducted in January 2025, assessed the spaceplane’s capabilities to manage powered payloads, a key step toward its inaugural mission to…
Read post
Volkswagen Considers U.S. Manufacturing for Porsche and Audi EVs Amid Tariff Threats
Volkswagen is contemplating the relocation of Porsche and Audi electric vehicle (EV) production to the United States. This move aims to counter the potential imposition of 25% tariffs on European imports, a proposal put forth by former President Donald Trump.…
Read post
Sony Ceases Production of Recordable Media Formats Including Blu-Ray, MiniDisc, and MiniDV
Sony has announced the cessation of production for several recordable media formats, including Blu-Ray discs, MiniDiscs, and MiniDV cassettes, effective immediately. This decision affects primarily the Japanese market and certain professional sectors elsewhere. Sony’s decision comes as a response to…
Read post
Nivolumab Boosts Response Rates in Estrogen Receptor-Positive Breast Cancer
A recent phase 3 trial has shown that adding nivolumab to standard neoadjuvant chemotherapy significantly improves pathological complete response (pCR) rates in high-risk estrogen receptor-positive (ER+), HER2-negative breast cancer. Conducted between November 2019 and April 2022, this study involved 510…
Read post
